Moderna Stock Performance

MRNA Stock  USD 34.01  0.66  1.90%   
On a scale of 0 to 100, Moderna holds a performance score of 8. The company secures a Beta (Market Risk) of 2.32, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Moderna will likely underperform. Please check Moderna's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Moderna's current price movements will revert.

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Moderna are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Moderna sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(1.90)
Five Day Return
4.81
Year To Date Return
(19.02)
Ten Year Return
82.85
All Time Return
82.85
1
Abu Dhabi feiert seine Hauptrolle in der Formel 1 The Movie auf der Yas Marina Rennstrecke
07/03/2025
2
Moderna Sees Bullish Movement with Increased Stock Price MRNA Stock News
07/10/2025
3
Why Moderna Stock Is Falling Today
07/14/2025
4
Las Vegas Sands breaks ground on US8 billion expansion at Marina Bay Sands
07/15/2025
5
Will 45 percent Of Work At Moderna Be Completed By AI By 2030 Yes
07/16/2025
6
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
07/18/2025
7
Moderna, Inc. Shares Purchased by Larson Financial Group LLC
07/21/2025
8
Moderna price target lowered by 1 at BofA, heres why MRNA
07/22/2025
9
Las Vegas Sands Exceeds Q2 Expectations with Strong Marina Bay Sands Revenue
07/24/2025
Begin Period Cash Flow2.9 B
Total Cashflows From Investing Activities1.9 B

Moderna Relative Risk vs. Return Landscape

If you would invest  2,746  in Moderna on April 26, 2025 and sell it today you would earn a total of  655.00  from holding Moderna or generate 23.85% return on investment over 90 days. Moderna is currently generating 0.4205% in daily expected returns and assumes 3.7349% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Moderna, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Moderna is expected to generate 4.75 times more return on investment than the market. However, the company is 4.75 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.22 per unit of risk.

Moderna Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Moderna's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Moderna, and traders can use it to determine the average amount a Moderna's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1126

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMRNA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.73
  actual daily
33
67% of assets are more volatile

Expected Return

 0.42
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.11
  actual daily
8
92% of assets perform better
Based on monthly moving average Moderna is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Moderna by adding it to a well-diversified portfolio.

Moderna Fundamentals Growth

Moderna Stock prices reflect investors' perceptions of the future prospects and financial health of Moderna, and Moderna fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Moderna Stock performance.

About Moderna Performance

By analyzing Moderna's fundamental ratios, stakeholders can gain valuable insights into Moderna's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Moderna has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Moderna has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 29.17  27.71 
Return On Tangible Assets(0.25)(0.24)
Return On Capital Employed(0.33)(0.31)
Return On Assets(0.25)(0.24)
Return On Equity(0.33)(0.31)

Things to note about Moderna performance evaluation

Checking the ongoing alerts about Moderna for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Moderna help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Moderna had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 3.24 B. Net Loss for the year was (3.56 B) with loss before overhead, payroll, taxes, and interest of (2.62 B).
Moderna currently holds about 8.35 B in cash with (3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.73.
Roughly 74.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: Las Vegas Sands Exceeds Q2 Expectations with Strong Marina Bay Sands Revenue
Evaluating Moderna's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Moderna's stock performance include:
  • Analyzing Moderna's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Moderna's stock is overvalued or undervalued compared to its peers.
  • Examining Moderna's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Moderna's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Moderna's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Moderna's stock. These opinions can provide insight into Moderna's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Moderna's stock performance is not an exact science, and many factors can impact Moderna's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated